Misfolded SOD1 and ALS: Zeroing in on mitochondria

Amyotrophic Lateral Sclerosis

Volumn 13, Issue 4, 2012, Pages 333-340

  Pickles, Sarah ^a   Vande Velde, Christine ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

ALS; Antibodies; Misfolded SOD1; Mitochondria; Motor neuron

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MITOCHONDRIAL PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN BCL 2; SEDI ANTIBODY; UNCLASSIFIED DRUG; USOD ANTIBODY; VOLTAGE DEPENDENT ANION CHANNEL 1;

AMYOTROPHIC LATERAL SCLEROSIS; CELL SURVIVAL; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MITOCHONDRION; MOTONEURON; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN UNFOLDING; REVIEW; TRANSGENE;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODIES; HUMANS; MITOCHONDRIA; MOTOR NEURONS; MUTATION; PROTEIN FOLDING; SUPEROXIDE DISMUTASE;

EID: 84861596118     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2012.648645     Document Type: Review

References (52)

1. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281:1851-1854.
2. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105-1116.
3. Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol. 2009;187:761-772.
4. Durham HD, Roy J, Dong L, Figlewicz DA. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J Neuropathol Exp Neurol. 1997;56: 523-30.
5. Prudencio M, Hart PJ, Borchelt DR, Andersen PM. Variation in aggregation propensities among ALS-Associated variants of SOD1: Correlation to human disease. Hum Mol Genet. 2009;18:3217-3226.
6. Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR. Role of mutant SOD1 disulphide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci U S A. 2009;106:7774-7779.
7. Rakhit R, Crow JP, Lepock JR, Kondejewski LH, Cashman NR, Chakrabartty A. Monomeric Cu/Zn superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J Biol Chem. 2004;279:15499-15504.
8. Furukawa Y, O'Halloran TV. Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation. J Biol Chem. 2005;280:17266-74.
9. Ip P, Mulligan VK, Chakrabartty A. ALS-causing SOD1 mutations promote production of copper-defi cient misfolded species. J Mol Biol. 2011;409:839-852.
10. Vassall KA, Stubbs HR, Primmer HA, Tong MS, Sullivan SM, Sobering R, et al. Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS. Proc Natl Acad Sci U S A. 2011;108:2210-2215.
11. Rakhit R, Robertson J, Vande Velde C, Horne P, Ruth DM, Griffi n J, et al. An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS. Nat Med. 2007;13:754-759.
12. Khare SD, Dokholyan NV. Common dynamical signatures of familial amyotrophic lateral sclerosis-Associated structurally diverse Cu/Zn superoxide dismutase mutants. Proc Natl Acad Sci U S A. 2006;103:3147-3152.
13. Rumfeldt JA, Lepock JR, Meiering EM. Unfolding and folding kinetics of amyotrophic lateral sclerosis-Associated mutant Cu/Zn superoxide dismutases. J Mol Biol. 2009;385: 278-98.
14. Mulligan VK, Kerman A, Ho S, Chakrabartty A. Denaturational stress induces formation of zinc-defi cient monomers of Cu/Zn superoxide dismutase: Implications for pathogenesis in amyotrophic lateral sclerosis. J Mol Biol. 2008;383: 424-36.
15. Liu HN, Sanelli T, Horne P, Pioro EP, Strong MJ, Rogaeva E, et al. Lack of evidence of monomer/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis. Ann Neurol. 2009;66:75-80.
16. Kerman A, Liu HN, Croul S, Bilbao J, Rogaeva E, Zinman L, et al. Amyotrophic lateral sclerosis is a non-Amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathol. 2010;119:335-344.
17. Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, et al. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One. 2010;5:e11552.
18. Zetterstrom P, Andersen PM, Brannstrom T, Marklund SL. Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients. J Neurochem. 2011;117:91-99.
19. Vande Velde C, Miller TM, Cashman NR, Cleveland DW. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci U S A. 2008;105:4022-4027.
20. Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, Shoshan-Barmatz V, et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron. 2010;67:575-587.
21. Strange RW, Yong CW, Smith W, Hasnain SS. Molecular dynamics using atomic-resolution structure reveal structural fl uctuations that may lead to polymerization of human Cu/Zn superoxide dismutase. Proc Natl Acad Sci U S A. 2007; 104:10040-4.
22. Grad LI, Guest WC, Yanai A, Pokrishevsky E, O'Neill MA, Gibbs E, et al. Intermolecular transmission of superoxide dismutase-1 misfolding in living cells. Proc Natl Acad Sci U S A. 2011;108:16398-16403.
23. Gros-Louis F, Soucy G, Lariviere R, Julien JP. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J Neurochem. 2010; 113:1188-1199.
24. Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci. 2006;9:108-118.
25. Urushitani M, Ezzi SA, Julien JP. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2007;104:2495-2500.
26. Bosco DA, Morfi ni G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13:1396-1403.
27. Hernandez S, Casanovas A, Piedrafi ta L, Tarabal O, Esquerda JE. Neurotoxic species of misfolded SOD1-G93A recognized by antibodies against the P2X4 subunit of the ATP receptor accumulate in damaged neurons of transgenic animal models of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2010;69:176-187.
28. Ezzi SA, Urushitani M, Julien JP. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem. 2007;102: 170-8.
29. Fujiwara N, Nakano M, Kato S, Yoshihara D, Ookawara T, Eguchi H, et al. Oxidative modifi cation to cysteine sulphonic acid of Cys111 in human copper-zinc superoxide dismutase. J Biol Chem. 2007;282:35933-44.
30. Watanabe S, Nagano S, Duce J, Kiaei M, Li QX, Tucker SM, et al. Increased affi nity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase-1 linked to amyotrophic lateral sclerosis. Free Radic Biol Med. 2007;42: 1534-42.
31. Okado-Matsumoto A, Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu/Zn SOD in mitochondria. J Biol Chem. 2001;276:38388-93.
32. Liu J, Lillo C, Jonsson PA, Vande Velde C, Ward CM, Miller TM, et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron. 2004;43:5-17.
33. Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, et al. Amyotrophic lateral sclerosis-Associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43:19-30.
34. Vijayvergiya C, Beal MF, Buck J, Manfredi G. Mutant superoxide dismutase-1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J Neurosci. 2005;25:2463-2470.
35. Bergemalm D, Jonsson PA, Graffmo KS, Andersen PM, Brannstrom T, Rehnmark A, et al. Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models. J Neurosci. 2006;26:4147-4154.
36. Goldsteins G, Keksa-Goldsteine V, Ahtoniemi T, Jaronen M, Arens E, Akerman K, et al. Deleterious role of superoxide dismutase in the mitochondrial intermembrane space. J Biol Chem. 2008;283:8446-8452.
37. Ahtoniemi T, Jaronen M, Keksa-Goldsteine V, Goldsteins G, Koistinaho J. Mutant SOD1 from spinal cord of G93A rats is destabilized and binds to inner mitochondrial membrane. Neurobiol Dis. 2008;32:479-485.
38. Pedrini S, Sau D, Guareschi S, Bogush M, Brown RH Jr, Naniche N, et al. ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Genet. 2010;19:2974-2986.
39. Yonashiro R, Sugiura A, Miyachi M, Fukuda T, Matsushita N, Inatome R, et al. Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation. Mol Biol Cell. 2009;20:4524-4530.
40. Kawamata H, Magrane J, Kunst C, King MP, Manfredi G. Lysyl-tRNA synthetase is a target for mutant SOD1 toxicity in mitochondria. J Biol Chem. 2008;283:28321-8.
41. Tsujimoto Y, Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ. 2000;7:1174-1181.
42. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 1999;399:483-487.
43. Arbel N, Shoshan-Barmatz V. Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity. J Biol Chem. 2010;285:6053-6062.
44. Li Q, Vande Velde C, Israelson A, Xie J, Bailey AO, Dong MQ, et al. ALS-linked mutant superoxide dismutase-1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci U S A. 2010;107:21146-51.
45. Vande Velde C, McDonald KK, Boukhedimi Y, McAlonis-Downes M, Lobsiger CS, Bel Hadj S, et al. Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS One. 2011;6:e22031.
46. Sotelo-Silveira JR, Lepanto P, Elizondo MV, Horjales S, Palacios F, Martinez PL, et al. Axonal mitochondrial clusters containing mutant SOD1 in transgenic models of ALS. Antioxid Redox Signal. 2009;11:1535-1545.
47. Mattiazzi M, D'Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem. 2002;277:29626-33.
48. Jung C, Higgins CM, Xu Z. Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J Neurochem. 2002;83: 535-45.
49. Panov AV, Kubalik N, Zinchenko N, Ridings DM, Radoff DA, Hemendinger R, et al. Metabolic and functional differences between brain and spinal cord mitochondria underlie different predisposition to pathology. Am J Physiol Regul Integr Comp Physiol. 2011;300:R844 - 54.
50. Damiano M, Starkov AA, Petri S, Kipiani K, Kiaei M, Mattiazzi M, et al. Neural mitochondrial Ca 2 - Capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn superoxide dismutase mutant mice. J Neurochem. 2006;96:1349-1361.
51. Tradewell ML, Cooper LA, Minotti S, Durham HD. C alcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: Mechanistic relationship and differential sensitivity to intervention. Neurobiol Dis. 2011;42:265-275.
52. Igoudjil A, Magrane J, Fischer LR, Kim HJ, Hervias I, Dumont M, et al. In vivo pathogenic role of mutant SOD1 localized in the mitochondrial intermembrane space. J Neurosci. 2011;31:15826-37.